6,368
Views
8
CrossRef citations to date
0
Altmetric
Review

Expert review on global real-world vaccine effectiveness against SARS-CoV-2

, , , , , ORCID Icon, ORCID Icon, , , , , , , , ORCID Icon, ORCID Icon, ORCID Icon, & show all
Pages 1255-1268 | Received 26 May 2022, Accepted 17 Jun 2022, Published online: 30 Jun 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, D. V. Dung, Kao-Pin Hwang, Javier Ortiz Ibarra, Sasisopin Kiertiburanakul, Prasad S. Kulkarni, Christopher Lee, Ping-Ing Lee, Rommel Crisenio Lobo, Alejandro Macias, Cao Huu Nghia, Anna Lisa Ong-Lim, Alfonso J. Rodriguez-Morales, Rosana Richtmann, Marco Aurélio Palazzi Safadi, Hindra Irawan Satari & Guy Thwaites. (2023) Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic. Expert Review of Vaccines 22:1, pages 1-16.
Read now
Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, Dung Do-Van, Kao-Pin Hwang, Sasisopin Kiertiburanakul, Ping-Ing Lee, Rommel Crisenio Lobo, Alejandro Macias, Cao Huu Nghia, Anna Ong-Lim, Javier Ortiz Ibarra, Rosana Richtmann, Alfonso J. Rodriguez-Morales, Marco Aurélio P Safadi & Hindra Irawan Satari. (2022) Further implications on the global real-world vaccine effectiveness against SARS-CoV-2. Expert Review of Vaccines 21:9, pages 1355-1357.
Read now

Articles from other publishers (6)

Carina C. D. Joe, Nitin Chopra, Piergiuseppe Nestola, Julia Niemann & Alexander D. Douglas. (2023) Rapid-response manufacturing of adenovirus-vectored vaccines. Nature Biotechnology 41:3, pages 314-316.
Crossref
Kannikar Intawong, Suwat Chariyalertsak, Kittipan Chalom, Thanachol Wonghirundecha, Woravut Kowatcharakul, Aksara Thongprachum, Narain Chotirosniramit, Worachet Teacharak, Pimpinan khammawan, Jarurin Waneesorn & Sopon Iamsirithaworn. (2023) Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study. The Lancet Regional Health - Southeast Asia 10, pages 100121.
Crossref
Jose Villar, Constanza P Soto Conti, Robert B Gunier, Shabina Ariff, Rachel Craik, Paolo I Cavoretto, Stephen Rauch, Serena Gandino, Ricardo Nieto, Adele Winsey, Camilla Menis, Gabriel B Rodriguez, Valeria Savasi, Niyazi Tug, Sonia Deantoni, Marta Fabre, Begoña Martinez de Tejada, Maria Jose Rodriguez-Sibaja, Stefania Livio, Raffaele Napolitano, Nerea Maiz, Helena Sobrero, Ashley Peterson, Philippe Deruelle, Carolina Giudice, Jagjit S Teji, Roberto A Casale, Laurent J Salomon, Federico Prefumo, Leila Cheikh Ismail, Michael G Gravett, Marynéa Vale, Valeria Hernández, Loïc Sentilhes, Sarah R Easter, Carola Capelli, Emily Marler, Daniela M Cáceres, Guadalupe Albornoz Crespo, Ernawati Ernawati, Michal Lipschuetz, Ken Takahashi, Carmen Vecchiarelli, Teresa Hubka, Satoru Ikenoue, Gabriela Tavchioska, Babagana Bako, Adejumoke I Ayede, Brenda Eskenazi, Jim G Thornton, Zulfiqar A Bhutta, Stephen H Kennedy & Aris T Papageorghiou. (2023) Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. The Lancet 401:10375, pages 447-457.
Crossref
Matthew Tze Jian Wong, Satvinder Singh Dhaliwal, Venugopal Balakrishnan, Fazlina Nordin, Mohd Nor Norazmi & Gee Jun Tye. (2023) Effectiveness of Booster Vaccinations on the Control of COVID-19 during the Spread of Omicron Variant in Malaysia. International Journal of Environmental Research and Public Health 20:2, pages 1647.
Crossref
Kannikar Intawong, Suwat Chariyalertsak, Kittipan Chalom, Thanachol Wonghirundecha, Woravut Kowatcharakul, Pisittawoot Ayood, Aksara Thongprachum, Narain Chotirosniramit, Kajohnsak Noppakun, Krit Khwanngern, Worachet Teacharak, Prapon Piamanant & Pimpinan Khammawan. (2023) Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand. International Journal of Infectious Diseases 126, pages 31-38.
Crossref
Marek Petráš, Roman Máčalík, Daniela Janovská, Alexander M. Čelko, Jana Dáňová, Eliška Selinger, Jonáš Doleček, Sylva Neradová, Martina Franklová, Pavel Dlouhý, Jozef Rosina & Ivana Králová Lesná. (2022) Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression. BMC Medicine 20:1.
Crossref